CFDE Data Portal | Search CDK13

	Label	Description
	GSE225375 CDK12 CDK13 inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225375 CDK12 CDK13 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225375 CDK12 CDK13 inhibition 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225375 CDK12 CDK13 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225375 CDK12 CDK13 inhibition 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	CDK13 associations Collection (Entity type)	Associations for CDK13_associations
	CDK13 Up Gene Set (Entity type)	A Gene Set from LINCS
	CDK13 Down Gene Set (Entity type)	A Gene Set from LINCS
	CDK13 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE225375 CDK12 CDK13 inhibition 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE225375 CDK12 CDK13 inhibition 1 v 3 human up

A Gene Set from LINCS

GSE225375 CDK12 CDK13 inhibition 2 v 3 human up

A Gene Set from LINCS

GSE225375 CDK12 CDK13 inhibition 2 v 0 human dn

A Gene Set from LINCS

GSE225375 CDK12 CDK13 inhibition 2 v 0 human up

A Gene Set from LINCS

GSE225375 CDK12 CDK13 inhibition 1 v 3 human dn

A Gene Set from LINCS

CDK13 associations

Associations for CDK13_associations

CDK13 Up

A Gene Set from LINCS

CDK13 Down

A Gene Set from LINCS

CDK13 associations.tsv

A file from IDG as part of the Harmonizome project

GSE225375 CDK12 CDK13 inhibition 2 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.